Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
REGN vs. RGEN: Which Stock Is the Better Value Option?
03:40pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
REGN vs. RGEN: Which Stock Is the Better Value Option?
REGN vs. RGEN: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 04'th Oct 2022
REGN vs. RGEN: Which Stock Is the Better Value Option?
Repligen: Now Best Biotech Nearby Cap-Gain Prospect
11:44am, Tuesday, 27'th Sep 2022
Biotech stocks' bad investment reputations often (not always) come from failed lab tests. But today's opportunity comes from overenergetic market correction. A week ago I highlighted BGNE as the most
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
08:01pm, Monday, 19'th Sep 2022 GlobeNewswire Inc.
Signs 15-year Strategic Collaboration and Exclusive License Agreement Signs 15-year Strategic Collaboration and Exclusive License Agreement
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
01:45pm, Monday, 19'th Sep 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Repligen (RGEN) is a Top-Ranked Growth Stock: Should You Buy?
11:17am, Monday, 19'th Sep 2022
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Checking In on 10 Stock Picks
02:00pm, Saturday, 17'th Sep 2022 The Motley Fool
Five stocks indistinguishable from magic and five stocks with a tailwind blow.
Checking In on 10 Stock Picks
10:00am, Saturday, 17'th Sep 2022
Five stocks indistinguishable from magic and five stocks with a tailwind blow.
Why Medical Products Maker Repligen May Be A Potential Buy
10:23am, Thursday, 15'th Sep 2022
Medical products maker Repligen has a long history of trouncing sales and earnings views, and it just boosted its full-year sales guidance. Is the stock a buy?
2 Top Healthcare Stocks to Buy for September
02:15pm, Thursday, 08'th Sep 2022 The Motley Fool
These companies bring different strengths and opportunities to a stock portfolio.
These 3 Stocks Are the Future of Biotechnology
02:36pm, Sunday, 04'th Sep 2022 The Motley Fool
Here's why three Fool.com contributors love Vertex Pharmaceuticals, Repligen, and Recursion Pharmaceuticals.
These 3 Stocks Are the Future of Biotechnology
10:36am, Sunday, 04'th Sep 2022
Here's why three Fool.com contributors love Vertex Pharmaceuticals, Repligen, and Recursion Pharmaceuticals.
Repligen (RGEN) Down 8.8% Since Last Earnings Report: Can It Rebound?
03:31pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Repligen (RGEN) Down 8.8% Since Last Earnings Report: Can It Rebound?
01:09pm, Thursday, 01'st Sep 2022
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Repligen To Host Investor Day 2022
11:30am, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
WALTHAM, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator of bioprocessing technologies and solutions, today announced that it will host “Repligen I
